Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cardiomyopathy: full-pipeline trial registry
10 of 26 indexed Cardiomyopathy trials are currently recruiting.
Corpus placement: #627 of 28,707 conditions by registered trial count.
26 US clinical trials · 10 currently recruiting · #627 of 28,707 conditions by registered trial count
Cardiomyopathy: 26 US clinical trials tracked, 10 recruiting.
Cardiomyopathy is the subject of 26 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Medtronic Cardiac Rhythm and Heart Failure, running 2 of these trials.
Enrollment posture brief
Registry condition cardiomyopathy
OPEN 10 | RECR 38% | LATE 3 | EARLY 4 | RANK #627 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Anaplastic Oligodendroglioma (38% recruiting · 13 trials)
Cardiomyopathy lists 10 open slots (38% of 26 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cardiomyopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cardiomyopathy recruits in line with its size-band peers.
10 of 26 indexed trials (38.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cardiomyopathy trials is spread across many organizations.
Medtronic Cardiac Rhythm and Heart Failure accounts for 2 of 26 trials (7.7%). 21 distinct sponsors appear on at least one study for this condition label.
-
Typical Cardiomyopathy enrolment sits around 72 participants.
Median target enrolment is 72 among the 26 trials that report a genuine target (sentinel values excluded). 14 of those (53.8%) plan for fewer than 100 participants.
-
Cardiomyopathy splits between interventional and observational designs.
13 interventional and 13 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
26 total, page 1 of 1
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
National Heart, Lung, and Blood Institute (NHLBI)
NCT01143454
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
University of Rochester
NCT06964464
Genetics of Cardiovascular and Neuromuscular Disease
University of Chicago
NCT00138931
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Tenaya Therapeutics
NCT05112237
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Mayo Clinic
NCT05507879
Molecular Imaging of Primary Amyloid Cardiomyopathy
Brigham and Women's Hospital
NCT02641145
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
M.D. Anderson Cancer Center
NCT02962661
Clinical Course Of Disease In Participants With FA-CM
Lexeo Therapeutics
NCT06865482
Impella Reverse Remodeling in End-Stage Heart Failure
Columbia University
NCT06800716
Large Language Models To Improve the Quality of Care of Cardiology Patients
Stanford University
NCT06935253
InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry
Medtronic Cardiac Rhythm and Heart Failure
NCT00273182
PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy
Medtronic Cardiac Rhythm and Heart Failure
NCT00253357
Telephone Intervention in Heart Failure Patients
US Department of Veterans Affairs
NCT00057057
Study Looking at the Recovery of New Onset Cardiomyopathy
University of Pittsburgh
NCT00575211
Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)
National Heart, Lung, and Blood Institute (NHLBI)
NCT04603521
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
National Institute of Environmental Health Sciences (NIEHS)
NCT01143519
Speckle Tracking in Pediatric Patients
Emory University
NCT00489957
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
University of California, San Diego
NCT02111993
Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure
Michael E. DeBakey VA Medical Center
NCT01261065
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
University of California, San Diego
NCT02111980
Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery
Corewell Health East
NCT00321295
Ventricular Arrhythmias in Uremic Cardiomyopathy
Northwell Health
NCT01856400
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation
Deborah Ascheim
NCT01442129
Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy
St. Jude Children's Research Hospital
NCT01071473
Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
Mayo Clinic
NCT01970176
Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines
M.D. Anderson Cancer Center
NCT02408432
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cardiomyopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cardiomyopathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cardiomyopathy page
26 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Cardiomyopathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Medtronic Cardiac Rhythm and Heart Failure sponsors the most Cardiomyopathy trials on record, review their full trial history before evaluating a specific study. See Medtronic Cardiac Rhythm and Heart Failure's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiomyopathy condition card totals 26 registered trials; most-linked intervention Mesenchymal Stem Cell Transplantation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.